CA3052295A1 - Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues - Google Patents

Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues Download PDF

Info

Publication number
CA3052295A1
CA3052295A1 CA3052295A CA3052295A CA3052295A1 CA 3052295 A1 CA3052295 A1 CA 3052295A1 CA 3052295 A CA3052295 A CA 3052295A CA 3052295 A CA3052295 A CA 3052295A CA 3052295 A1 CA3052295 A1 CA 3052295A1
Authority
CA
Canada
Prior art keywords
cells
ectopic
subject
tissue
signaling pathway
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3052295A
Other languages
English (en)
French (fr)
Inventor
Eric Lagasse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
University of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pittsburgh filed Critical University of Pittsburgh
Publication of CA3052295A1 publication Critical patent/CA3052295A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
CA3052295A 2017-02-17 2018-02-20 Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues Pending CA3052295A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762460267P 2017-02-17 2017-02-17
US62/460,267 2017-02-17
US201762574119P 2017-10-18 2017-10-18
US62/574,119 2017-10-18
PCT/US2018/018684 WO2018152488A1 (en) 2017-02-17 2018-02-20 Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues

Publications (1)

Publication Number Publication Date
CA3052295A1 true CA3052295A1 (en) 2018-08-23

Family

ID=63170490

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3052295A Pending CA3052295A1 (en) 2017-02-17 2018-02-20 Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues

Country Status (12)

Country Link
US (2) US20190374583A1 (cg-RX-API-DMAC7.html)
EP (1) EP3582794B1 (cg-RX-API-DMAC7.html)
JP (3) JP2020508298A (cg-RX-API-DMAC7.html)
KR (2) KR102762505B1 (cg-RX-API-DMAC7.html)
CN (2) CN119097642A (cg-RX-API-DMAC7.html)
AU (1) AU2018221254B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019016965A2 (cg-RX-API-DMAC7.html)
CA (1) CA3052295A1 (cg-RX-API-DMAC7.html)
ES (1) ES3070490T3 (cg-RX-API-DMAC7.html)
IL (2) IL268389B2 (cg-RX-API-DMAC7.html)
MX (2) MX2019009367A (cg-RX-API-DMAC7.html)
WO (1) WO2018152488A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4427813A3 (en) * 2019-04-11 2024-12-18 University of Pittsburgh- Of the Commonwealth System of Higher Education Minimally invasive cell transplant procedure to induce the development of in vivo organogenesis
WO2023076279A1 (en) * 2021-10-25 2023-05-04 Satellite Biosciences, Inc. Engineered tissue constructs for the treatment of crigler-najjar syndrome
CN116925997B (zh) * 2023-07-27 2024-04-02 湖北医药学院 左氧氟沙星在制备促进细胞增殖中的药物的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312691B1 (en) 1996-01-26 2001-11-06 Jeffrey L. Browning Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents
ATE371018T1 (de) * 2001-06-22 2007-09-15 Stemcells Inc Le-zellen (liver engrafting cells), assays und verwendungen davon
US9125891B2 (en) * 2008-03-07 2015-09-08 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph nodes as a site for regeneration
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
US11191785B2 (en) * 2008-03-07 2021-12-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
AU2012352454A1 (en) * 2011-12-15 2014-07-17 The University Of Chicago Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors

Also Published As

Publication number Publication date
MX2019009367A (es) 2019-10-24
JP7784392B2 (ja) 2025-12-11
KR20250020727A (ko) 2025-02-11
MX2024005097A (es) 2024-05-15
IL268389A (en) 2019-09-26
EP3582794C0 (en) 2026-04-22
JP2025176014A (ja) 2025-12-03
JP2023061960A (ja) 2023-05-02
IL310219A (en) 2024-03-01
US20240091271A1 (en) 2024-03-21
IL310219B1 (en) 2026-03-01
ES3070490T3 (en) 2026-06-16
WO2018152488A1 (en) 2018-08-23
US20190374583A1 (en) 2019-12-12
AU2018221254B2 (en) 2025-03-20
EP3582794B1 (en) 2026-04-22
BR112019016965A2 (pt) 2020-04-14
EP3582794A4 (en) 2020-12-09
CN119097642A (zh) 2024-12-10
CN110869032B (zh) 2024-08-23
KR20190116439A (ko) 2019-10-14
IL268389B2 (en) 2024-06-01
IL268389B1 (en) 2024-02-01
EP3582794A1 (en) 2019-12-25
CN110869032A (zh) 2020-03-06
AU2018221254A1 (en) 2019-08-15
KR102762505B1 (ko) 2025-02-03
IL310219B2 (en) 2026-07-01
JP2020508298A (ja) 2020-03-19

Similar Documents

Publication Publication Date Title
US20240091271A1 (en) Fat-associated lymphoid clusters as sites for transplantation, tissue regeneration, organogenesis and function for multiple tissues
Houlihan et al. Critical review of clinical trials of bone marrow stem cells in liver disease
Reinders et al. Mesenchymal stromal cell therapy for solid organ transplantation
Citro et al. Directed self-assembly of a xenogeneic vascularized endocrine pancreas for type 1 diabetes
CN103989710A (zh) 分离的肝脏干细胞
AU2017225825A1 (en) Improved preparations of adult liver progenitor cells
US20250144146A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
US20210024885A1 (en) Methods and compositions for producing hepatocytes
WO2014138486A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
CN101356264A (zh) 分离的肝脏干细胞
HK40021179B (en) Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues
US20250195579A1 (en) Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
HK40021179A (en) Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues
Hallett The Human Hepatic Progenitor Cell as a Transplantable Source of Biliary Regeneration
Tanimizu et al. Generation of functional liver tissue by establishing hepatobiliary connections ex vivo
Shi Transplantation of Monocyte-derived Hepatocyte-like Cells (NeoHep cells) Improves Survival in A Model of Acute Liver Failure
Shi Transplantation von hepatozytenähnlichen Zellen (NeoHep Zellen) verbessert das Überleben in einem Modell akuten Leberversagens

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220816

D15 Examination report completed

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT

Effective date: 20241223

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 7TH ANNIV.) - STANDARD

Year of fee payment: 7

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250214

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250214

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250214

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20250414

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250415

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250718

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250718

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260213

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260213

D22 Grant of ip right intended

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D22-D128 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALLOWANCE REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20260616

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260616